Timber Pharmaceuticals, Inc.
(NYSE Amex Equities : TMBR)

( )
TMBR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 0.06%34.530.9%$1198.63m
JNJJohnson & Johnson 1.45%143.010.7%$1100.23m
BMYBristol-Myers Squibb Co. 1.79%60.201.0%$994.35m
MRKMerck & Co., Inc. 0.98%79.550.7%$855.54m
ABBVAbbVie, Inc. 0.14%99.021.9%$793.07m
LLYEli Lilly & Co. 1.89%166.961.1%$705.44m
AZNAstraZeneca Plc 0.56%54.101.2%$303.42m
RPRXRoyalty Pharma Plc 0.83%46.110.1%$241.25m
VXRTVaxart, Inc. -12.62%6.440.0%$210.18m
NVSNovartis AG 1.03%88.470.2%$160.09m
RGENRepligen Corp. -0.05%126.597.1%$122.67m
GSKGlaxoSmithKline Plc -0.51%41.010.2%$120.98m
NVONovo Nordisk A/S -0.65%65.930.1%$95.27m
RETAReata Pharmaceuticals, Inc. 1.63%160.433.4%$86.28m
SNYSanofi 1.12%52.200.2%$77.07m

Company Profile

Timber Pharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, tuberous sclerosis complex and localized scleroderma. The company is headquartered in Campbell, CA.